Australia
AVANCE CLINICAL APPOINTS US-BASED EXECUTIVES - SVP SCIENTIFIC AND REGULATORY AFFAIRS, AND DIRECTOR BUSINESS DEVELOPMENT
ADELAIDE, Australia and RALEIGH, N.C., Sept. 21, 2023 /PRNewswire/ -- Avance
Clinical, the award-winning Australian and North American market-leading CRO
for biotechs, announces two key appointments in the US to support its continued
global growth.
2023-09-21 19:30
1660
Körber celebrates partnership milestone with Geek+
HAMBURG, Germany, Sept. 20, 2023 /PRNewswire/ -- Global strategic partnership
empowers businesses to overcome efficiency, scalability and sustainability
challenges across supply chain
Körber
2023-09-20 18:34
1879
Norgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer
AMSTERDAM, Sept. 11, 2023 /PRNewswire/ -- Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment ofSaulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience...
2023-09-11 15:00
1258
World Orphan Drug Alliance Welcomes Specialised Therapeutics
* SEA's largest independent specialty pharma company Specialised Therapeutics (ST) has joined global pharma consortium committed to collaborating to provide new specialist medicines for rare diseases. * ST to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA). * Wor...
2023-09-08 04:00
1726
Discover the Legumes From Europe project. Which legumes have the highest amounts of protein and why you should make them part of your diet.
SYDNEY, Sept. 5, 2023 /PRNewswire/ -- Encouraging the consumption of legumes is one of the objectives of theLegumes from Europe campaign led by ANICAV – the National Association of Canned Vegetable Industries – and co-funded by the European Union to promote a healthier and more active lifestyle, ...
2023-09-05 15:00
1561
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
* Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform * ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging early immunogenicity data * ACM is in partnering d...
2023-09-05 14:00
1558
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial
Highlights * First participant of cohort 3 in the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been treated at the highest dose level of 12GBq. * Cohort 2 was recently completed in 3 participants who received therapy...
2023-08-25 20:58
2704
Noodoe Links Californian and Australian Efforts to Combat Global Climate Change
With its newly opened Brisbane offices, Noodoe enables businesses from California to Australia to drive the adoption of sustainable transportation. IRVINE, Calif., Aug. 17, 2023 /PRNewswire/ -- Noodoe today announced the opening of its new offices inBrisbane, Australia as the next step in its wor...
2023-08-18 03:47
2096
THE CONQUEROR TEAMS UP WITH WARNER BROS. DISCOVERY GLOBAL CONSUMER PRODUCTS TO LAUNCH THE ULTIMATE SERIES OF VIRTUAL FITNESS CHALLENGES INSPIRED BY HBO'S GAME OF THRONES
Five Challenges, Five Medals, Following the Extraordinary Journeys of Jon Snow, Tyrion Lannister,Arya Stark, Daenerys Targaryen, and more. TAURANGA, New Zealand, Aug. 16, 2023 /PRNewswire/ -- The Conqueror Virtual Challenges, in collaboration with Warner Bros. Discovery Global Consumer Products,...
2023-08-16 14:00
1688
Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis
SAN DIEGO, SHANGHAI and SYDNEY, Aug. 15, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, announced that the first patient has been dosed in a glob...
2023-08-15 22:50
2357
HB11 Energy receives grant from US Department of Energy to develop clean, safe and unlimited fusion energy
SYDNEY, Aug. 15, 2023 /PRNewswire/ -- The U.S. Department of Energy (DoE) has
awarded a grant toHB11 Energy
2023-08-15 21:00
1687
Clarity's theranostic prostate cancer trial advances to highest dose level
Highlights * Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been completed in 3 participants who received therapy with67Cu SAR-bisPSMA at the dose level of 8GBq. * No dose limiting toxicities (DLTs) ha...
2023-08-10 20:58
2367
AI-based wastewater sampling predicts COVID pressure on hospitals
SYDNEY, Aug. 7, 2023 /PRNewswire/ -- New research shows it is possible to
accurately predict hospital admission numbers due to COVID-19 up to four weeks
in advance with an Artificial Intelligence (AI) based system using COVID
wastewater sampling.
2023-08-07 21:13
1638
Relume Launches World's First AI-Powered Site Builder that exports to Webflow and Figma
SYDNEY, Aug. 7, 2023 /PRNewswire/ -- Sydney-based startup Relume has launched the world's first AI-powered site builder that exports to Webflow and Figma. The new site builder allows users to easily create website wireframes with just a prompt and export them to Figma and Webflow, saving time and...
2023-08-07 15:00
1284
Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting
SYDNEY, Aug. 2, 2023 /PRNewswire/ -- Arbele, a clinical-stage biotechnology company developing novel immunotherapies targeted for advanced gastrointestinal cancers, presented early safety data from its first-in-class CDH17xCD3 bispecific T-cell engager antibody, ARB202, at the ASCO Breakthrough c...
2023-08-03 07:00
1295
GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME
* YONDELIS® (trabectedin) now PBS listed for Australian patients * Listing described as "wonderful news" for patients living with rare lipo and leiomyo sarcomas * YONDELISÒ (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine1 SINGAPORE, July 31...
2023-07-31 15:00
1673
Gem Rock Auctions Celebrates Remarkable Milestone of Selling 1 Million Exquisite Gemstones Online
GOLD COAST, Australia, July 30, 2023 /PRNewswire/ -- Gem Rock Auctions, the leading online marketplace for gemstones, celebrates a remarkable milestone as its 320 sellers worldwide have collectively sold over 1 million gemstones to 179 countries. With an impressive inventory of over 1,000 gemston...
2023-07-31 07:00
1540
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
* HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's CAR-T cell therapy in patients with kappa-type myeloma * The agreement is the culmination of previous preclinical research collaboration b...
2023-07-25 19:30
1295
Clarity reaches 50% recruitment milestone for Phase II SABRE prostate cancer trial
SYDNEY, July 24, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity", "the Company"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce the Phas...
2023-07-24 21:02
1809
New 6clicks Trust Portal Features Combine Transparency and Security for Sharing Compliance and Privacy Information with Customers and Partners
Trust Management System Puts an End to "One Size Fits All" Privacy and
Compliance Statements and Enables Granular Control of Disclosure
MELBOURNE, Australia, July 12, 2023 /PRNewswire/ -- 6clicks
2023-07-13 06:31
2027
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5209
